Calistoga Tells Del. Justices It Earned $50M Drug Bonus
Attorneys for a Calistoga Pharmaceuticals Inc. stockholder agent told Delaware's Supreme Court Monday that the state chancellor incorrectly qualified the terms for a $50 million drug-approval bonus earlier this year, letting...To view the full article, register now.
Already a subscriber? Click here to view full article